CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 45,046 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 18,622 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 18,622 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 7,500 shares at $4.00 ($30,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 5,455 shares at $5.50 ($30,003)
- 4 Open-market buy Chief Executive Officer bought 2,591 shares at $3.86 ($10,001)
- 4 Open-market buy Chief Executive Officer bought 2,841 shares at $3.52 ($10,000)
- 4 Open-market buy Chief Executive Officer bought 32,259 shares at $0.31 ($10,000)
Page 9 of 18 · 343 filings